Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematological Malignancies

Investigators described a step-wise, directed-differentiation protocol in which organoids are generated from iPSCs committed to mesenchymal, endothelial, and hematopoietic lineages.